Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy

Hepatology

Volumn 32, Issue 5, 2000, Pages 1163-1169

  Cho, Sung Won ^a   Hahm, Ki Baik ^a   Kim, Jin Hong ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG WITHDRAWAL; FEMALE; GENE DELETION; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SEROCONVERSION; STOP CODON; VIRUS GENE; VIRUS GENOME; VIRUS LOAD;

EID: 0033760350     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.19618     Document Type: Article

References (34)

1. Analysis of liver disease, nuclear HBcAg, viral replication and hepatitis B virus in liver and serum of HBeAg vs. anti-HBe positive chronic hepatitis B virus infection
2. Natural history of chronic hepatitis B virus infection in Taiwan: Studies of hepatitis B virus DNA in serum
3. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B
4. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients
5. Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis
6. Mutation preventing formation of e antigen in patients with chronic HBV infection
7. Viral genetic variation: Hepatitis B virus as a clinical sample
8. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pregenome encapsidation signal
9. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis
10. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees
11. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication
12. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis
13. Hepatitis B viruses with pre-core region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen
14. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment
15. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial
16. A preliminary trial of lamivudine for chronic hepatitis B infection
17. Lamivudine therapy for chronic hepatitis B: A six-month randomized dose ranging study
18. A one-year trial for lamivudine for chronic hepatitis B
19. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/ hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B
20. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
21. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients
22. Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon
23. Changes of precore nucleic acid sequence in chronic hepatitis B patients with and without interferon administration
24. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation
25. Significance of pre-S region-defective hepatitis B virus that emerged during exacerbation of chronic type B hepatitis
26. Posttranscriptional regulation of hepatitis B virus replication by the precore protein
27. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice
28. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation
29. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen
30. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B
31. Analysis of hepatitis B virus genotype and pre-core region variability during interferon treatment of HBeAg negative chronic hepatitis B
32. Analysis of hepatitis B virus population in an interferon-α-treated patient reveals predominant mutations in the c-gene and changing e-antigenicity
33. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection
34. Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation